Below is a summary of our committee structure and membership information. To read more about any of the members of our committees, click on the committee member's names in the chart below.
Chairperson Chairperson Committee Member Member
 Audit Committee Remuneration Committee Corporate Governance and Nominating Committee
Lawrence  M. Alleva 
Lawrence  M. Alleva
Non-Executive Director


Lawrence (Larry) Alleva has served as a Non‑Executive Director since March 2015. Mr. Alleva is a former partner with PricewaterhouseCoopers LLP (PwC), where he worked for 39 years from 1971 until his retirement in June 2010, including 28 years' service as a partner.

Mr. Alleva worked with numerous pharmaceutical and biotechnology companies as clients and, additionally, served PwC in a variety of office, regional and national practice leadership roles, most recently as the U.S. Ethic... 

Chairperson   
Ali  Behbahani, MD 
Ali  Behbahani, MD
Non-Executive Director


Dr. Ali Behbahani has served as a Non-Executive Director since February 2015 and formerly served as a Non-Executive Director of Adaptimmune Limited since September 2014, initially in a capacity as a nominee of New Enterprise Associates 14 LP, (NEA), one of our shareholders.

Dr. Behbahani has been a Partner on the healthcare team at NEA since 2013, having worked for the fund since 2007, specializing in investments in the biopharmaceutical, medical device, specialty pharmaceutical and... 

   Committee Member
Barbara Duncan 
Barbara Duncan
Non-Executive Director


Barbara Duncan has served as a Non-Executive Director since June 2016. She has over 15 years of experience in the life sciences industry and served as Chief Financial Officer and Treasurer at Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) from May 2009 through June 2016, and as Chief Financial Officer and then Chief Executive Officer at DOV Pharmaceuticals, Inc. from 2001 to 2009.

Prior to joining DOV, Ms. Duncan served as Vice President of Corporate Finance - Global Healthcare at L... 

Committee Member   
John Furey 
John Furey
Non-Executive Director


John Furey has served as a Non-Executive Director since July 2018.

Mr. Furey is Chief Operating Officer at Spark Therapeutics, Inc, where he is responsible for global commercial operations, medical affairs, technology development and technical operations. He has substantial experience of developing and implementing operational strategies and leading commercial and technical teams.

Prior to joining Spark Therapeutics, Mr. Furey was senior vice president and head of global o... 

  Committee Member  
Giles Kerr 
Giles Kerr
Non-Executive Director


Giles Kerr has served as a Non-Executive Director since November 2016. He has substantial commercial and financial experience gained from service on numerous public and private company boards and as an audit partner. Mr. Kerr has served as Director of Finance of the University of Oxford since 2005. He also currently serves as a Board member and Audit Committee member of public companies BTG plc (LSE: BTG), Paypoint plc (LSE: PAY), Senior plc (LSE: SNR) and Arix Bioscience plc (LSE: ARIX) and ... 

Committee Member   Committee Member
David  M. Mott 
David  M. Mott
Chairman


David Mott has served as our Chairman since January 2017 and as a Non-Executive Director since February 2015. He formerly served as a Non-Executive Director of Adaptimmune Limited since September 2014, initially in a capacity as a nominee of New Enterprise Associates 14 LP (NEA), one of our shareholders. Mr. Mott has served as a General Partner of NEA, an investment firm focused on venture capital and growth equity investments, since 2008, and leads its healthcare investing practice.

<... 
  Chairperson Chairperson
Elliott  Sigal, MD, PhD 
Elliott  Sigal, MD, PhD
Non-Executive Director


Dr. Elliott Sigal has served as a Non-Executive Director since February 2015 and formerly served as a Non-Executive Director of Adaptimmune Limited since September 2014. Dr. Sigal is a former Executive Vice President and member of the Board of Directors of Bristol-Myers Squibb (BMS). He joined BMS in 1997 as head of Applied Genomics, went on to head Discovery Research followed by clinical development and ultimately served as Chief Scientific Officer and President of R&D from 2004 until 2013.<... 

   Committee Member
Tal Zaks, MD, PhD 
Tal Zaks, MD, PhD
Non-Executive Director


Dr. Tal Zaks has served as a Non-Executive Director since November 2016. He has substantial research, development and commercialization experience gained from service in industry and academia. Dr. Zaks has served as the Chief Medical Officer of Moderna Therapeutics, Inc. since March 2015. He previously served as Senior Vice President and Head of Global Oncology at Sanofi Inc, where he was responsible for all aspects of oncology drug discovery, development and commercialization.

Dr. ... 

  Committee Member